Aplastic Anemia with Epstein-Barr Virus Reactivation after Anti-thymocyte Globulin Therapy

Yo Kawarada,Ryujiro Hara,Toshihiko Kitahara,Hiroki Numata,Shigeki Watanabe,Masatoshi Yamada,Kiyoshi Ando
DOI: https://doi.org/10.2169/internalmedicine.0539-22
2023-09-01
Abstract:Lymphoproliferative disorders and Epstein-Barr virus reactivation (EBV-LPDs) have various forms of onset, ranging from infectious mononucleosis-like syndrome (IM-like) to lymphoma, although whether or not IM-like progresses to lymphoma remains unclear. A 61-year-old man was diagnosed with aplastic anemia (AA). Polyclonal atypical B-lymphocytes were observed in the peripheral blood, and IM-like was diagnosed. Atypical lymphocytes disappeared, but a gastrointestinal examination revealed diffuse large B-cell lymphoma (DLBCL). Rituximab was initiated but later discontinued because of severe acute respiratory syndrome coronavirus 2 infection. Pancytopenia due to AA exacerbation recurred. The patient ultimately died of multiple organ failure due to bacterial infection.
What problem does this paper attempt to address?